Clinical relevance of the molecular analysis of circulating tumor cells (CTC)

被引：0
|
作者：
Albert, Winfried H. [1 ]
Lustig, Michael [1 ]
Lankiewicz, Silke [1 ]
Hauch, Siegfried [1 ]
机构：
[1] AdnaGen AG, D-03853 Langenhagen, Germany
来源：
TUMOR BIOLOGY | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [21] Multi-parameter molecular characterization of circulating tumor cells (CTC): Development of a CTC-endocrine therapy index (CTC-ETI)
    Paoletti, Costanza
    Brown, Martha
    Muniz, Maria
    Rae, James M.
    Thomas, Dafydd G.
    Hayes, Daniel F.
    CANCER RESEARCH, 2011, 71
  • [22] Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer
    Banys-Paluchowski, M.
    Schneck, H.
    Blassl, C.
    Schultz, S.
    Meier-Stiegen, F.
    Niederacher, D.
    Krawczyk, N.
    Ruckhaeberle, E.
    Fehm, T.
    Neubauer, H.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2015, 75 (03) : 232 - 237
  • [23] Current biological implications and clinical relevance of metastatic circulating tumor cells
    Shahhosseini, Reza
    Pakmehr, Seyedabbas
    Elhami, Anis
    Shakir, Maha Noori
    Alzahrani, Abdullah Ali
    Al-Hamdani, Mais Mazin
    Abosoda, Munther
    Alsalamy, Ali
    Mohammadi-Dehcheshmeh, Majid
    Maleki, Tahereh Ezazi
    Saffarfar, Hossein
    Ali-Khiavi, Payam
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 25 (01)
  • [24] Circulating tumor cells: Isolation, quantification, and relevance of their translation into clinical practice
    Olivier Gomez, C.
    Carballido Rodriguez, J.
    ACTAS UROLOGICAS ESPANOLAS, 2010, 34 (01): : 3 - 5
  • [25] Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer
    Papadaki, Maria A.
    Koutsopoulos, Anastasios, V
    Tsoulfas, Panormitis G.
    Lagoudaki, Eleni
    Aggouraki, Despoina
    Monastirioti, Alexia
    Koutoulaki, Chara
    Apostolopoulou, Christina A.
    Merodoulaki, Aikaterini C.
    Papadaki, Chara
    Mavroudis, Dimitrios
    Agelaki, Sofia
    CANCERS, 2020, 12 (02)
  • [26] Circulating Tumor Cells: Clinically Relevant Molecular Access Based on a Novel CTC Flow Cell
    Winer-Jones, Jessamine P.
    Vahidi, Behrad
    Arquilevich, Norma
    Fang, Cong
    Ferguson, Samuel
    Harkins, Darren
    Hill, Cory
    Klem, Erich
    Pagano, Paul C.
    Peasley, Chrissy
    Romero, Juan
    Shartle, Robert
    Vasko, Robert C.
    Strauss, William M.
    Dempsey, Paul W.
    PLOS ONE, 2014, 9 (01):
  • [27] Detection of circulating tumor cells: Clinical relevance of a novel metastatic tumor marker (Review)
    Ren, Chuanli
    Han, Chongxu
    Wang, Daxin
    Zhao, Xiaohang
    Jin, Guangfu
    Shen, Hongbing
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (03) : 385 - 391
  • [28] Molecular characterization of circulating tumor cells (CTC) and CTC. subpopulations in baseline and progressive metastatic castration resistant prostate cancer (mCRPC)
    Dittamore, Ryan
    Louw, Jessica
    Krupa, Rachel
    Danila, Daniel Costin
    Arslan, Zaina
    Schreiber, Nicole A.
    Bales, Natalee
    Marrinucci, Dena
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] Molecular Analysis of Circulating Tumor Cells in Prostate Cancer
    Miyamoto, David T.
    ONCOLOGIST, 2015, 20 : S6 - S6
  • [30] Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer
    Mostert, Bianca
    Sleijfer, Stefan
    Foekens, John A.
    Gratama, Jan Willem
    CANCER TREATMENT REVIEWS, 2009, 35 (05) : 463 - 474
12345